Rare diseases
Investigational molecules
Locations
Back to France1 094 clinical trials in Montpellier, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceStudy on the Safety and Tolerability of Lixudebart and Rituximab for Patients with Rapidly Progressive Glomerulonephritis Due to ANCA-Associated Vasculitis
FranceStudy Comparing Mosunetuzumab and Lenalidomide with Other Treatments for Patients with Relapsed or Refractory Marginal Zone Lymphoma
FranceStudy on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer
FranceStudy Comparing 177Lu-Edotreotide and Everolimus for Patients with Neuroendocrine Tumors in the Lung and Thymus
FranceStudy on Capsaicin Patch for Treating Chronic Neuropathic Pain in Children Aged 12-17
FranceStudy on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia
FranceLong-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer
FranceStudy on Linezolid and Vancomycin for Preventing Surgical Site Infections in Patients Undergoing Surgery
FranceStudy of Glofitamab with Rituximab or Obinutuzumab and Drug Combination for Untreated Richter's Syndrome Patients
FranceFranceStudy on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancer, bladder cancer, and mantle cell lymphoma. Studies evaluate combination therapies and novel treatment approaches for improved patient outcomes.
Research includes evaluation of immunotherapy combinations and targeted molecular approaches.
Studies examining innovative treatments for Crohn's disease, multiple sclerosis, and systemic sclerosis. Research focuses on novel therapeutic approaches and treatment optimization.
Trials aim to improve disease management and patient quality of life.
Investigating treatments for achondroplasia, pyruvate dehydrogenase deficiency, and thyroid eye disease. Focus on developing targeted therapies for these uncommon conditions.
Research aims to address unmet medical needs in rare disease populations.
Clinical trials evaluating vaccines for cytomegalovirus, yellow fever, and HPV prevention. Studies focus on immunization effectiveness and safety profiles.
Research emphasizes disease prevention and public health improvement.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
